SALVIA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 26.440
EU - Europa 25.276
AS - Asia 18.277
SA - Sud America 2.571
AF - Africa 613
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 73.250
Nazione #
US - Stati Uniti d'America 25.803
RU - Federazione Russa 10.118
SG - Singapore 7.346
CN - Cina 5.187
GB - Regno Unito 4.694
IT - Italia 3.027
BR - Brasile 2.070
HK - Hong Kong 1.605
VN - Vietnam 1.573
DE - Germania 1.492
SE - Svezia 1.292
FR - Francia 1.207
IE - Irlanda 1.112
FI - Finlandia 795
KR - Corea 544
BD - Bangladesh 462
CA - Canada 354
IN - India 318
NL - Olanda 318
UA - Ucraina 270
JP - Giappone 264
AR - Argentina 191
ES - Italia 182
MX - Messico 182
TR - Turchia 170
NG - Nigeria 134
PL - Polonia 132
ID - Indonesia 129
AT - Austria 123
ZA - Sudafrica 122
IQ - Iraq 113
BE - Belgio 88
CZ - Repubblica Ceca 80
TG - Togo 78
PK - Pakistan 77
BJ - Benin 62
EC - Ecuador 61
LT - Lituania 56
MA - Marocco 56
CO - Colombia 55
UZ - Uzbekistan 55
VE - Venezuela 54
AU - Australia 49
CL - Cile 41
PH - Filippine 41
SA - Arabia Saudita 41
AE - Emirati Arabi Uniti 39
JO - Giordania 39
PY - Paraguay 38
CH - Svizzera 36
EG - Egitto 35
NP - Nepal 33
KE - Kenya 31
TN - Tunisia 30
IL - Israele 29
IR - Iran 27
AZ - Azerbaigian 26
PE - Perù 26
RO - Romania 26
KG - Kirghizistan 21
AL - Albania 20
PT - Portogallo 20
JM - Giamaica 19
LV - Lettonia 19
DZ - Algeria 18
SI - Slovenia 18
KZ - Kazakistan 17
MY - Malesia 17
GR - Grecia 16
HU - Ungheria 16
UY - Uruguay 16
HR - Croazia 15
RS - Serbia 15
BO - Bolivia 14
LB - Libano 13
OM - Oman 13
BG - Bulgaria 12
CR - Costa Rica 12
NO - Norvegia 12
DK - Danimarca 11
PA - Panama 11
DO - Repubblica Dominicana 9
GT - Guatemala 9
LU - Lussemburgo 9
SK - Slovacchia (Repubblica Slovacca) 9
BY - Bielorussia 8
ET - Etiopia 8
EU - Europa 8
HN - Honduras 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
EE - Estonia 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
BH - Bahrain 6
GA - Gabon 6
KW - Kuwait 6
NZ - Nuova Zelanda 6
Totale 73.126
Città #
Singapore 3.954
Southend 3.902
Moscow 3.675
Dallas 3.156
Ashburn 3.126
San Jose 2.592
Chandler 2.454
Hong Kong 1.581
Jacksonville 1.384
Verona 1.242
Dublin 1.080
Woodbridge 1.070
The Dalles 921
Beijing 871
New York 677
Ann Arbor 646
Houston 608
Council Bluffs 591
Ho Chi Minh City 529
Los Angeles 511
Munich 456
Lawrence 374
Princeton 374
Wilmington 352
Jinan 350
Hanoi 345
Nanjing 293
Helsinki 255
Shenyang 255
Santa Clara 239
Buffalo 236
Tokyo 228
São Paulo 224
Milan 193
Redondo Beach 189
Sindelfingen 185
Orem 178
Redmond 177
Tianjin 175
Hebei 170
Columbus 160
London 158
Turku 143
Hangzhou 131
Montreal 131
Haikou 127
Seattle 124
Abuja 121
Zhengzhou 120
Warsaw 114
Frankfurt am Main 110
Amsterdam 108
Ningbo 108
Toronto 106
Stockholm 103
Rome 102
Denver 101
Changsha 100
Chennai 100
Guangzhou 98
Taiyuan 95
Nanchang 89
Brooklyn 87
San Francisco 85
Taizhou 85
Atlanta 84
Brussels 84
Johannesburg 80
Rio de Janeiro 80
Boardman 79
Lancaster 79
Lomé 78
Da Nang 77
Bologna 76
Nuremberg 75
Chicago 74
Jiaxing 74
Fairfield 71
Phoenix 71
Poplar 71
Seoul 70
Falkenstein 68
Lappeenranta 67
Haiphong 66
Jakarta 66
Mexico City 65
Vienna 65
Belo Horizonte 63
Cotonou 62
Washington 62
Mumbai 52
Redwood City 52
Brno 51
Manchester 50
Paris 49
Fuzhou 47
Tashkent 47
Norwalk 46
Falls Church 45
Kent 43
Totale 44.913
Nome #
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 392
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 335
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 282
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Genomic characterization of hepatoid tumors: context matters 261
Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. 256
(Intraductal papillary mucinous tumors) Clinical manifestations and therapeutic management. 254
Genomic analyses identify molecular subtypes of pancreatic cancer 254
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 252
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 250
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 249
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 248
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 246
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 244
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 241
Gα15 in early onset of pancreatic ductal adenocarcinoma 239
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 238
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 238
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 237
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 236
[Closed surgical treatment in acute severe pancreatitis] 235
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 231
A root-cause analysis of mortality following major pancreatectomy 228
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions 227
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 226
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 222
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 220
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 220
A multimodality test to guide the management of patients with a pancreatic cyst 220
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 219
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 219
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 218
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 218
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 216
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 216
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 215
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 214
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 213
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 212
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 212
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 212
Triple approach strategy for patients with locally advanced pancreatic carcinoma 210
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 210
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 210
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 209
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 209
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 207
An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging 207
Delaying surgery for patients with a previous SARS-CoV-2 infection 204
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 204
Beyond Pancreatic Cyst Epithelium: Evidence of Ovarian-Like Stroma in EUS-Guided Through-the-Needle Micro-Forceps Biopsy Specimens 203
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 203
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 199
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 197
MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution(Article) [Risonanza magnetica (RM) e colangiopancreatografia con RM (CPRM) dei tumori intraduttali papillari mucino-secernenti (TIPM) multifocali dei dotti pancreatici secondari: Semeiotica ed evoluzione] 195
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 195
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 195
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 195
Sex differences in oncogenic mutational processes 195
Pancreatic Hepatoid Carcinoma: A Review of the Literature 194
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 193
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 193
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 193
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 192
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 192
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis 192
Anastomotic leakage in pancreatic surgery. 191
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 191
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review 190
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 190
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 190
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula - Results of a prospective study in 137 patients 189
Anastomotic leakage in pancreatic surgery. 189
Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. 188
Erratum to: Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up 188
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 188
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 188
Anastomotic leakeage in pancreatic surgery 187
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 187
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Ablation treatments in unresectable pancreatic cancer 185
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 185
Enucleation of pancreatic neoplasms. 184
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 184
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 184
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 183
An unforeseeable adverse event during ERCP 182
Prophylaxis for septic complications in acute necrotizing pancreatitis 181
Incidence of cancer in the course of chronic pancreatitis 181
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 180
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 179
Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization 179
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 179
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 178
Totale 21.222
Categoria #
all - tutte 250.097
article - articoli 240.824
book - libri 0
conference - conferenze 3.639
curatela - curatele 0
other - altro 377
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.257
Totale 500.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 0 0 0 0 0 172
2021/20222.926 271 700 58 193 114 105 73 198 146 76 258 734
2022/20237.190 459 779 594 1.193 590 1.700 148 559 815 73 169 111
2023/20244.246 155 362 390 510 456 648 267 278 64 168 703 245
2024/202511.074 583 569 408 1.724 614 353 725 580 1.571 748 1.100 2.099
2025/202636.142 2.305 2.145 2.861 5.698 8.888 2.338 3.147 1.966 2.918 2.080 752 1.044
Totale 74.025